Chembio Diagnostics Inc 's

Name: Chembio Diagnostics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CEMI Sales vs. its Competitors Q4 2022

Comparing the current results to its competitors, Chembio Diagnostics Inc reported Revenue decrease in the 4 quarter 2022 year on year by -49.72 %, faster than the overall decrease of Chembio Diagnostics Inc 's competitors by -49.72 %, recorded in the same quarter.

• List of CEMI Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Chembio Diagnostics Inc recorded a net loss, as well as most of its competitors.

<< CEMI Stock Performance Comparisons

<< See the full list of CEMI competitors

Overall company Market Share Q4 2022

despite revenue deterioration, Chembio Diagnostics Inc increased its market share in this segment. company improved its market share in this segment. << More on CEMI Market Share.

*Market share is calculated based on total revenue.

CEMI's Stock Performance relative to its Competitors

Publicly Traded Peers of Chembio Diagnostics Inc

Bluejay Diagnostics Inc
Share Performance

-12.37%

30 Days

Bluejay Diagnostics Inc

Profile

Bluejay Diagnostics Inc follows a business model where they develop and manufacture diagnostic tests and medical devices for a variety of health conditions, aiming to provide accurate and efficient solutions to healthcare professionals and patients. They primarily operate by selling their products to hospitals, clinics, and other medical institutions.

More about Bluejay Diagnostics Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1.913 mill.	$ - mill.	$ -7.271 mill.

Cardio Diagnostics Holdings Inc
Share Performance

-28.17%

This Year

Cardio Diagnostics Holdings Inc

Profile

Cardio Diagnostics Holdings Inc is a medical diagnostics company that specializes in cardiovascular health. Their business model focuses on developing and commercializing innovative diagnostic solutions for detecting and monitoring heart-related conditions. By leveraging advanced technologies and partnerships, they aim to provide healthcare professionals with accurate and timely information to enhance their patients' cardiovascular care.

More about Cardio Diagnostics Holdings Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 6.037 mill.	$ 0.014 mill.	$ -6.470 mill.

Sources: Chembio Diagnostics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 3, 2026 11:35 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Chembio Diagnostics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.